Genetic influences on serum bilirubin in American Indians: The strong heart family study

American Journal of Human Biology

Volumn 23, Issue 1, 2011, Pages 118-125

  Melton, Phillip E ^a   Haack, Karin ^a   Göring, Harald H ^a   Laston, Sandy ^a   Umans, Jason G ^b   Lee, Elisa T ^c   Fabsitz, Richard R ^d   Devereux, Richard B ^e   Best, Lyle G ^f   Maccluer, Jean W ^a   Almasy, Laura ^a   Cole, Shelley A ^a  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^b MEDSTAR RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f MISSOURI BREAKS INDUSTRIES RESEARCH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; BILIRUBIN URIDINE DIPHOSPHOGLUCURONOSYL TRANSFERASE 1A1; BILIRUBIN URIDINE-DIPHOSPHOGLUCURONOSYL TRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE;

AMERICAN INDIAN; ARTICLE; BLOOD; CHROMOSOME 2; CHROMOSOME MAP; FEMALE; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENETICS; GENOTYPE; HUMAN; HYPERBILIRUBINEMIA; MALE; METABOLISM; PEDIGREE; STATISTICS; UNITED STATES;

BILIRUBIN; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 2; FEMALE; GENETIC VARIATION; GENOTYPE; GLUCURONOSYLTRANSFERASE; HUMANS; HYPERBILIRUBINEMIA; INDIANS, NORTH AMERICAN; LOD SCORE; MALE; PEDIGREE; POLYMORPHISM, GENETIC; UNITED STATES;

EID: 78650163068     PISSN: 10420533     EISSN: 15206300     Source Type: Journal    
DOI: 10.1002/ajhb.21114     Document Type: Article

References (36)

1. Almasy L, Blangero J. 2004. Exploring positional candidate genes: linkage conditional on measured genotype. Behav Genet 34: 173-177.
2. Almasy L, Blangero J. 1998. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62: 1198-1211.
3. Antzelevitch C, Pollevick GD, Cordeiro JM, Casis O, Sanguinetti MC, Aizawa Y, Guerchicoff A, Pfeiffer R, Oliva A, Wollnik B, Gelber P, Bonaros EP Jr, Burashnikov E, Wu Y, Sargent JD, Schickel S, Oberheiden R, Bhatia A, Hsu LF, Haïssaguerre M, Schimpf R, Borggrefe M, Wolpert C. 2007. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 115: 442-449.
4. Bosma PJ. 2003. Inherited disorders of bilirubin metabolism. J Hepatol 38: 107-117.
5. Bosma PJ, van der Meer IM, Bakker CT, Hofman A, Paul-Abrahamse M, Witteman JC. 2003. UGT1A1*28 allele and coronary heart disease: the Rotterdam study. Clin Chem 49: 1180-1181.
6. Breimer LH, Wannamethee G, Ebrahim S, Shaper AG. 1995. Serum bilirubin and risk of ischemic heart disease in middle-aged British men. Clin Chem 41: 1504-1508.
7. Djoussé L, Levy D, Cupples LA, Evans JC, D'Agostino RB, Ellison RC. 2000. Total serum bilirubin and risk of cardiovascular disease in the Framingham Offspring study. Am J Cardiol 87: 1196-1200.
8. Feingold E, Brown PO, Siegmund D. 1993. Gaussian models for genetic linkage analysis using complete high-resolution maps of identity by descent. Am J Hum Genet 53: 234-251.
9. Gajdos V, Petit FM, Perret C, Mollet-Boudjemline A, Colin P, Capel L, Nicaud V, Evans A, Arveiler D, Parisot F, Francoual J, Genin E, Cambien F, Labrune P. 2006. Further evidence that the UGT1A1*28 allele is not associated with coronary heart disease: the ECTIM study. Clin Chem 52: 2313-2314.
10. Hall D, Ybazeta G, Destro-Bisol G, Petzl-Erler ML, Di Rienzo A. 1999. Variability at the uridine diphosphate glucuronosyltransferase 1A1 promoter in human populations and primates. Pharmacogenetics 9: 591-599.
11. Hong AL, Huo D, Kim HJ, Niu Q, Fackenthal DL, Cummings SA, John EM, West DW, Whittemore AS, Das S, Olopade OI. 2007. UDP-glucuronosyltransferase 1A1 gene polymorphisms and total bilirubin levels in an ethnically diverse cohort of women. Drug Metab Dispos 35: 1254-1261.
12. Hopkins PN, Wu LL, Hunt SC, James BC, Vincent GM, Williams RR. 1996. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol 16: 250-255.
13. Howard BV, Welty TK, Fabsitz RR, Cowan LD, Oopik AJ, Le NA, Yeh J, Savage PJ, Lee ET. 1992. Risk factors for coronary heart disease in diabetic and nondiabetic Native Americans. The strong heart study. Diabetes 41 Suppl 2: 4-11.
14. Howard BV, Lee ET, Cowan LD, Devereux RB, Galloway JM, Go OT, Howard WJ, Rhoades ER, Robbins DC, Sievers ML, Welty TK. 1999. Rising tide of cardiovascular disease in American Indians. The strong heart study. Circulation 99: 2389-2395.
15. Hunt SC, Kronenberg F, Eckfeldt JH, Hopkins PN, Myers RH, Heiss G. 2001. Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI family heart study. Atherosclerosis 154: 747-754.
16. Johnson AD, Kavousi M, Smith AV, Chen MH, Dehghan A, Aspelund T, Lin JP, van Duijn CM, Harris TB, Cupples LA, Uitterlinden AG, Launer L, Hofman A, Rivadeneira F, Stricker B, Yang Q, O'Donnell CJ, Gudnason V, Witteman JC. 2009. Genome-wide association meta-analysis for total serum bilirubin levels. Hum Mol Genet 18: 2700-2710.
17. Kronenberg F, Coon H, Gutin A, Abkevich V, Samuels ME, Ballinger DG, Hopkins PN, Hunt SC. 2002. A genome scan for loci influencing anti-atherogenic serum bilirubin levels. Eur J Hum Genet 10: 539-546.
18. Lee ET, Welty TK, Fabsitz R, Cowan LD, Le NA, Oopik AJ, Cucchiara AJ, Savage PJ, Howard BV. 1990. The strong heart study. A study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol 132: 1141-1155.
19. Lin JP, Cupples LA, Wilson PW, Heard-Costa N, O'Donnell CJ. 2003. Evidence for a gene influencing serum bilirubin on chromosome 2q telomere: a genomewide scan in the Framingham study. Am J Hum Genet 72: 1029-1034.
20. Lin JP, O'Donnell CJ, Schwaiger JP, Cupples LA, Lingenhel A, Hunt SC, Yang S, Kronenberg F. 2006. Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham heart study. Circulation 114: 1476-1481.
21. Lin JP, Schwaiger JP, Cupples LA, O'Donnell CJ, Zheng G, Schoenborn V, Hunt SC, Joo J, Kronenberg F. 2009. Conditional linkage and genome-wide association studies identify UGT1A1*28-233.
22. Lingenhel A, Kollerits B, Schwaiger JP, Hunt SC, Gress R, Hopkins PN, Schoenborn V, Heid IM, Kronenberg F. 2008. Serum bilirubin levels, UGT1A1 polymorphisms and risk for coronary artery disease. Exp Gerontol 43: 1102-1107.
23. London B, Michalec M, Mehdi H, Zhu X, Kerchner L, Sanyal S, Viswanathan PC, Pfahnl AE, Shang LL, Madhusudanan M, Baty CJ, Lagana S, Aleong R, Gutmann R, Ackerman MJ, McNamara DM, Weiss R, Dudley SCJr. 2007. Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac NA+ current and causes inherited arrhythmias. Circulation 116: 2260-2268.
24. North KE, Howard BV, Welty TK, Best LG, Lee ET, Yeh JL, Fabsitz RR, Roman MJ, MacCluer JW. 2003. Genetic and environmental contributions to cardiovascular disease risk in American Indians: the strong heart family study. Am J Epidemiol 157: 303-314.
25. Rantner B, Kollerits B, Anderwald-Stadler M, Klein-Weigel P, Gruber I, Gehringer A, Haak M, Schnapka-Kopf M, Fraedrich G, Kronenberg F. 2008. Association between the UGT1A1 TA-repeat polymorphism and bilirubin concentration in patients with intermittent claudication: results from the CAVASIC study. Clin Chem 54: 851-857.
26. Rutherford S, Cai G, Lopez-Alvarenga JC, Kent JW, Voruganti VS, Proffitt JM, Curran JE, Johnson MP, Dyer TD, Jowett JB, Bastarrachea RA, Atwood LD, Goring HH, Maccluer JW, Moses EK, Blangero J, Comuzzie AG, Cole SA. 2007. A chromosome 11q quantitative-trait locus influences change of blood-pressure measurements over time in Mexican Americans of the San Antonio family heart study. Am J Hum Genet 81: 744-755.
27. Sanna S, Busonero F, Maschio A, McArdle PF, Usala G, Dei M, Lai S, Mulas A, Piras MG, Perseu L, Masala M, Marongiu M, Crisponi L, Naitza S, Galanello R, Abecasis GR, Shuldiner AR, Schlessinger D, Cao A, Uda M. 2009. Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia. Hum Mol Genet 18: 2711-2718.
28. Schwertner HA. 1998. Association of smoking and low serum bilirubin antioxidant concentrations. Atherosclerosis 136: 383-387.
29. Schwertner HA, Fisher JRJr. 2000. Comparison of various lipid, lipoprotein, and bilirubin combinations as risk factors for predicting coronary artery disease. Atherosclerosis 150: 381-387.
30. Schwertner HA, Jackson WG, Tolan G. 1994. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 40: 18-23.
31. Schwertner HA, Vitek L. 2008. Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis 198: 1-11.
32. Sedlak TW, Snyder SH. 2004. Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle. Pediatrics 113: 1776-1782.
33. Smith NF, Figg WD, Sparreboom A. 2005. Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination. Expert Opin Drug Metab Toxicol 1: 429-445.
34. Taviaux S, Williams ME, Harpold MM, Nargeot J, Lory P. 1997. Assignment of human genes for beta 2 and beta 4 subunits of voltage-dependent Ca2+ channels to chromosomes 10p12 and 2q22-q23. Hum Genet 100: 151-154.
35. Williams ME, Feldman DH, McCue AF, Brenner R, Velicelebi G, Ellis SB, Harpold MM. 1992. Structure and functional expression of alpha 1, alpha 2, and beta subunits of a novel human neuronal calcium channel subtype. Neuron 8: 71-84.
36. Wu TW, Fung KP, Wu J, Yang CC, Weisel RD. 1996. Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins. Biochem Pharmacol 51: 859-862.